相关实验视频
Updated: Jun 4, 2025

06:47
A Murine Model of Vertical Sleeve Gastrectomy
Published on: December 18, 2017
11.1K
介肠内脏液体切除 (MVL) 改善了2型糖尿病患者的葡萄糖耐受性:试点研究
Gozde Baskoy1, Richard Peterson1, Jason Kempenich1
1Texas Diabetes Institute and UT Health San Antonio, Texas.
The Journal of clinical endocrinology and metabolism
|December 17, 2024
概括
在2型糖尿病患者中,通过中腔内脏脂切术 (MVL) 去除内脏脂肪可以改善血糖控制和胰岛素敏感性. 这种微创手术方法在治疗2型糖尿病方面显得有前途.
科学领域:
- 代谢手术 代谢手术
- 内分泌学 在内分泌学.
- 糖尿病研究 糖尿病研究
背景情况:
- 腹腔内脏脂肪增加与代谢综合征,胰岛素耐药性和2型糖尿病有关.
- 肥胖和2型糖尿病经常并存,加剧了代谢功能障碍.
研究的目的:
- 评估清除小肠中肠脂肪对血糖控制和胰岛素敏感性的影响.
- 评估一种新型的最小侵入性方法对2型糖尿病管理的有效性.
主要方法:
- 利用向细胞分离和提取技术 (TC-SET) 进行中肠脂肪去除.
- 研究了7名肥胖,控制不良的2型糖尿病患者 (HbA1c 8.9%).
- 在12个月内监测血糖控制 (HbA1c,FPG,CGM),胰岛素敏感性,葡萄糖生产和身体成分.
主要成果:
- 6个月后HbA1c和FPG的显著降低,随着时间范围 (CGM) 的持续改善.
- 增加了内源性葡萄糖生产的抑制,胰岛素分泌量和排放指数增加了两倍以上.
- 体重,身体脂肪百分比和肝脏脂肪含量下降;全身葡萄糖排放没有显著变化.
结论:
- 介肠内脏脂肪切除术 (MVL) 显示出作为一种新的,最少侵入性的治疗方法,可以改善2型糖尿病的血糖控制.
- 需要进一步的受控研究来验证这些发现,并阐明MVL的全部好处.
相关概念视频
Dipeptidyl Peptidase 4 Inhibitors
167
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
167
Carbohydrate Metabolism
10.8K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.8K
Diabetes: Management and Pharmacotherapy
234
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
234
Chronic Pancreatitis II: Collaborative Care
70
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
70
Acute Pancreatitis II: Clinical Manifestations and Management
93
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
93
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
155
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
155

